Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4
- Status
- TERMINATED
- Phase
- N/A
Tarceva. ICORG 08-41
- Status
- COMPLETED
- Phase
- N/A
Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy
- Status
- SUSPENDED
- Phase
- PHASE4
Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]
- Status
- TERMINATED
- Phase
- PHASE1
VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- N/A
Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention
- Status
- COMPLETED
- Phase
- NA
Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
- Status
- COMPLETED
- Phase
- PHASE2
Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
- Status
- COMPLETED
- Phase
- N/A
A Study of LY3023414 in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1